Genprex, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 30.86 million compared to USD 23.74 million a year ago. Basic loss per share from continuing operations was USD 22.56 compared to USD 19.8 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.47 USD | -3.14% | +3.35% | -73.15% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-73.15% | 5.35M | |
+9.95% | 115B | |
+11.98% | 106B | |
-2.59% | 21.96B | |
-12.67% | 21.87B | |
-5.29% | 19.21B | |
-3.84% | 18.08B | |
-38.57% | 17.71B | |
+7.12% | 14.32B | |
+35.11% | 12.42B |
- Stock Market
- Equities
- GNPX Stock
- News Genprex, Inc.
- Genprex, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023